2026-2034年全球蛋白質體學市場規模、佔有率、趨勢和成長分析報告

預計蛋白質體學市場將從 2025 年的 447.9 億美元成長到 2034 年的 1,440.6 億美元，2026 年至 2034 年的複合年成長率為 13.86%。

受生物技術進步和生命科學研究不斷深入的推動，全球蛋白質體學市場經歷了顯著成長。蛋白質體學是對蛋白質進行大規模研究的學科，在闡明疾病機制和藥物發現方面發揮著至關重要的作用。慢性病盛行率的上升和個人化醫療需求的日益成長，正在加速對質譜和蛋白質微陣列等蛋白質組學技術的需求。

主要成長要素包括製藥和生技公司研發投入的增加。政府資助和學術研究計畫​​也促進了市場擴張。技術進步提高了蛋白質分析的準確性和效率，從而加深了對細胞過程的理解。此外，蛋白質體學在臨床診斷和生物標記發現中的日益普及也推動了市場成長。

未來，蛋白質體學市場有望透過與人工智慧 (AI) 和巨量資料分析的融合而不斷擴張。這些技術將提升數據解讀能力，並加速研究成果的發展。精準醫療和標靶治療的新應用預計將進一步推動市場需求。隨著醫療保健產業持續專注於創新，蛋白質體學仍將是推動醫學研究和改善患者照護的重要工具。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球蛋白質體學市場：依成分分類

• 市場分析、洞察與預測
• 裝置
• 試劑和試劑盒
• 軟體和服務

第5章：全球蛋白質體學市場：依方法論分類

• 市場分析、洞察與預測
• 蛋白質微陣列
• X光晶體結構分析
• 光譜學
• 層析法
• 蛋白質分級分離
• 電泳
• 表面等離子體共振
• 其他

第6章 全球蛋白質體學市場：依應用分類

• 市場分析、洞察與預測
• 藥物發現與開發
• 臨床診斷
• 癌症研究
• 個人化醫療
• 其他

第7章 全球蛋白質體學市場：依最終用戶分類

• 市場分析、洞察與預測
• 生物技術和製藥公司
• CRO（藥物研發合約研究組織）
• 學術和研究機構
• 醫院和臨床檢查室
• 其他

第8章 全球蛋白質體學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc
  • Merck KGaA
  • Illumina Inc
  • Bruker Corporation
  • Bio-Rad Laboratories Inc
  • Waters Corporation
  • Beckman Coulter Inc
  • Cell Signaling Technology Inc
  • Promega Corporation
  • Danaher Corporation（DH Life Sciences LLC）
  • Quantum-Si Incorporated
  • SomaLogic Operating Co. Inc
  • Seer Inc
  • Nautilus Biotechnology Inc

The Proteomics Market size is expected to reach USD 144.06 Billion in 2034 from USD 44.79 Billion (2025) growing at a CAGR of 13.86% during 2026-2034.

The global proteomics market has experienced significant growth, driven by advancements in biotechnology and increasing research in life sciences. Proteomics, the large-scale study of proteins, plays a critical role in understanding disease mechanisms and drug development. The rising prevalence of chronic diseases and the need for personalized medicine have accelerated the demand for proteomics technologies, including mass spectrometry and protein microarrays.

Key growth drivers include increased investment in research and development by pharmaceutical and biotechnology companies. Government funding and academic research initiatives also contribute to market expansion. Technological advancements have improved the accuracy and efficiency of protein analysis, enabling deeper insights into cellular processes. Additionally, the growing adoption of proteomics in clinical diagnostics and biomarker discovery supports market growth.

In the future, the proteomics market is expected to expand with the integration of artificial intelligence and big data analytics. These technologies will enhance data interpretation and accelerate research outcomes. Emerging applications in precision medicine and targeted therapies will further drive demand. As the healthcare industry continues to focus on innovation, proteomics will remain a key tool in advancing medical research and improving patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Instruments
• Reagents & Kits
• Software and Services

By Technique

• Protein Microarray
• X-Ray Crystallography
• Spectroscopy
• Chromatography
• Protein Fractionation
• Electrophoresis
• Surface Plasma Resonance
• Others

By Application

• Drug Discovery & Development
• Clinical Diagnostics
• Cancer Research
• Personalized Medicine
• Others

By End-user

• Biotech & Pharma Companies
• Contract Research Organization (CROs)
• Academic & Research Institutions
• Hospitals & Clinical Laboratories
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Agilent Technologies Inc, Merck KGaA, Illumina Inc, Bruker Corporation, BioRad Laboratories Inc, Waters Corporation, Beckman Coulter Inc, Cell Signaling Technology Inc, Promega Corporation, Danaher Corporation DH Life Sciences LLC, QuantumSi Incorporated, SomaLogic Operating Co Inc, Seer Inc, Nautilus Biotechnology Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PROTEOMICS MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROTEOMICS MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique
• 5.2. Protein Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. X-Ray Crystallography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Protein Fractionation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Surface Plasma Resonance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROTEOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROTEOMICS MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Biotech & Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organization (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals & Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PROTEOMICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Technique
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Technique
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Technique
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Technique
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Technique
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PROTEOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Agilent Technologies Inc
  • 10.2.3 Merck KGaA
  • 10.2.4 Illumina Inc
  • 10.2.5 Bruker Corporation
  • 10.2.6 Bio-Rad Laboratories Inc
  • 10.2.7 Waters Corporation
  • 10.2.8 Beckman Coulter Inc
  • 10.2.9 Cell Signaling Technology Inc
  • 10.2.10 Promega Corporation
  • 10.2.11 Danaher Corporation (DH Life Sciences LLC)
  • 10.2.12 Quantum-Si Incorporated
  • 10.2.13 SomaLogic Operating Co. Inc
  • 10.2.14 Seer Inc
  • 10.2.15 Nautilus Biotechnology Inc